Cargando…
Patterns of health care utilization related to initiation of amitriptyline, duloxetine, gabapentin, or pregabalin in fibromyalgia
INTRODUCTION: Several pharmacologic treatments are available for fibromyalgia, but little is known about the comparative effectiveness of these treatments on health care utilization. METHODS: Using US commercial insurance claims data (covering 2007 to 2009), we conducted a cohort study to examine th...
Autores principales: | Kim, Seoyoung C, Landon, Joan E, Lee, Yvonne C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4343277/ https://www.ncbi.nlm.nih.gov/pubmed/25627453 http://dx.doi.org/10.1186/s13075-015-0530-8 |
Ejemplares similares
-
Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia
por: Peng, X, et al.
Publicado: (2014) -
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial
por: Tesfaye, Solomon, et al.
Publicado: (2022) -
Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain
por: Quilici, Sibilia, et al.
Publicado: (2009) -
Evaluation of efficacy and safety of gabapentin, duloxetine, and pregabalin in patients with painful diabetic peripheral neuropathy
por: Devi, Padmini, et al.
Publicado: (2012) -
Impact of potential pregabalin or duloxetine drug–drug interactions on health care costs and utilization among Medicare members with fibromyalgia
por: Ellis, Jeffrey J, et al.
Publicado: (2014)